Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade

Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade

Background Subgroup analyses of randomized trials suggest the superiority of immune checkpoint inhibitor-based therapy over chemotherapy in patients with mismatch-repair deficient (dMMR) and/or microsatellite instability-high (MSI-high) advanced gastric or gastroesophageal junction adenocarcinoma. H...

Full description

Bibliographic Details
Main Authors: Akihito Kawazoe, Kohei Shitara, Sara Lonardi, Filippo Pietrantonio, Samuel J Klempner, Thierry André, Massimiliano Salati, Margherita Ambrosini, Giovanni Randon, Romain Cohen, Paolo Manca, Vincenzo Nasca, Joseph Chao, Leonardo Provenzano, Yu Aoki, Steven B Maron, Riccardo Cerantola, Lorenzo Fornaro, Walter Ferrari Bravo, Filippo Ghelardi, Valerie Zhu, Darren Cowzer, Virginia Genovesi
Format: Article
Language:English
Published: BMJ Publishing Group 2023-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/6/e007104.full

Internet

https://jitc.bmj.com/content/11/6/e007104.full

Similar Items